Press Releases

ADDISON, Ill., March 12, 2020 /PRNewswire/ -- Today Arjo announced a new distribution partnership with therapeutic seating provider Seating Matters. The partnership provides Arjo with exclusive access to the entire Seating Matters portfolio of solutions for both acute and long-term care customers.Experience the interactive Multichannel News Release here

CARMIEL, Israel, March 12, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that it has suc

WEST PALM BEACH, Fla., March 12, 2020 /PRNewswire/ -- EXUMA Biotech Corp. (formerly F1 Oncology), a clinical-stage biotechnology company discovering and developing CAR-T therapies for solid and liquid tumors, today announced a $19M Series B round of financing that includes new investments by MSD Partners and F1 BioVentures, as well as

LEXINGTON, Mass., March 12, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Agenus Fast Track designation for investigation of balstilimab [PD-1] in combination with zalifrelimab [C

FAIRFAX, Va., March 12, 2020 /PRNewswire/ -- Stroke victims deserve the same urgency and level of care as trauma patients, say stroke surgeons, patients and other advocates with the Get Ahead of Stroke campaign who are recommending life-saving changes to stroke protocols as part of the 25th anniversary of Brain Awareness Week from March 16 to

LEXINGTON, Mass., March 12, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers provided a corporate update and reported financial results for the fourth quarter and full year of 2019.

OLDWICK, N.J., March 12, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019.

ST. LOUIS, March 12, 2020 /PRNewswire/ -- Centene (NYSE: CNC) today announced that it is extending coverage for COVID-19. This important step is being taken in partnership with other major insurers and with the support of the White House Coronavirus Task Force.  Centene intends to cover COVID-19 testing and screening services for Medicaid, Medicare

LOS GATOS, Calif., March 12, 2020 /PRNewswire/ -- NuVera Medical, Inc., a portfolio company of Shifamed LLC, has been awarded the "Top 25 Cardiac Imaging Leaders 2020" honor from Cardiology2.0 Magazine as recognition for the impact the company is making in the cardiac imaging space."NuVera is reinventing the imaging modality for complex cardiac transcatheter

New Approach Entails a Defined Antibody Combination Targeting Multiple Epitopes and Mechanisms of Viral Evasion VICTORIA, March 12, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF), following its announcement to develop innovative treatments against the new coronavirus, SARS-